“…Drugs Selected for Evaluation. The 5 anticonvulsant compounds classified as nonsubstrates by our model ensemble and selected for experimental evaluation were methylparaben (Compound 12, Figure 2), 79 2-(2-oxo-2Hchromen-3-yl)benzoic acid (Compound 1, Figure 2), 1-methyl-1,2,3′,4′-tetrahydro-1′H-spiro[indole-3,2′-quinazoline]-2,4′dione (Compound 16, Figure 2), N-(3,3-dimethylbutan-2-yl)-2-methylfuran-3-carboxamide (Compound 17, Figure 2), 71,72 and N,N′-dibenzylsulfamide (Compound 13, Figure 2). 80 Experimental Model Validation.…”